✦ LIBER ✦

Cytomegalovirus pneumonia in patients with lymphoma

✍ Scribed by Roy F. Chemaly; Harrys A. Torres; Ray Y. Hachem; Graciela M. Nogueras; Elizabeth A. Aguilera; Anas Younes; Mario A. Luna; Gilhen Rodriguez; Jeffrey J. Tarrand; Issam I. Raad

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 129 KB
Volume: 104
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.21294

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Propionibacterium acnes pneumonia in a p

Propionibacterium acnes pneumonia in a patient with lymphoma

✍ Z. Mohsenifar; D. Klonoff; S. Cassan 📂 Article 📅 1979 🏛 Springer-Verlag 🌐 English ⚖ 826 KB

Fatal pneumocystis jiroveci pneumonia in

Fatal pneumocystis jiroveci pneumonia in ABVD-treated Hodgkin lymphoma patients

✍ Mats Kalin; Sigurdur Yngvi Kristinsson; Honar Cherif; Marianne Lebbad; Magnus Bj 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 78 KB

Disseminated strongyloidiasis and cytome

Disseminated strongyloidiasis and cytomegalovirus infection in a patient with anaplastic large cell lymphoma

✍ Jalil Ur Rehman; T. Vasudev Rao; Salam AlKindi; David Dennison; A. V. Pathare 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 102 KB

Fatal hemorrhagic pneumonia caused bySte

Fatal hemorrhagic pneumonia caused byStenotrophomanas maltophiliain a patient with non-Hodgkin lymphoma

✍ Naoto Takahashi; Toshiaki Yoshioka; Yoshihiro Kameoka; Hiroyuki Tagawa; Naohito 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 462 KB

Legionella pneumophila pneumonia associa

Legionella pneumophila pneumonia associated with reactivation of cytomegalovirus infection

✍ A. Löwenberg; H. J. Sluiter; T. Hauw The 📂 Article 📅 1985 🏛 Springer-Verlag 🌐 English ⚖ 696 KB

Cytomegalovirus prophylaxis with valganc

Cytomegalovirus prophylaxis with valganciclovir in cytomegalovirus-seropositive kidney-transplant patients

✍ Hugo Wéclawiak; Nassim Kamar; Catherine Mengelle; Joëlle Guitard; Laure Esposito 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

## Abstract The aims of this prospective, open‐label, single‐center pilot study were to assess the efficacy and safety of human cytomegalovirus (HCMV) prophylaxis using valganciclovir in HCMV‐ seropositive kidney‐transplant patients to prevent HCMV infection and disease. Fifty‐one HCMV seropositive